DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Jain MR, Giri SR, Bhoi B. , et al.
Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.
Liver Int 2018;
38 (06) 1084-1094
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.